McMinn Rachel - Insider Stock Trading - OpenInsider

CIK: 1606302 - Address: C/O Neurogene Inc., 535 W 24Th Street, 5Th Floor, New York, NY 10011

17 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	13	-1	-3	-6	-8	-15	-29	-10
S	%wins				69	62	58	64	90	83	71

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/25/24 21:29	11/22/24	NGNE	Neurogene Inc.		Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	DO	CEO	P	969	20.40	0	48	4	1,298	D
10/4/17 21:00	10/2/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-17	58.89	0	0	-2	17	D
8/2/17 20:59	7/31/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-16	123.12	0	0	-1	17	D
7/5/17 21:00	7/3/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-31	121.78	0	0	-1	17	D
5/3/17 21:01	5/1/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-13	113.12	33	0	-1	18	D	-55	-23	-7	5	-1	6	7	2	4	3
4/5/17 21:01	4/3/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-30	115.00	33	0	-1	18	D	-59	-26	-31	9	-8	-11	-4	0	-1	-1	7
1/5/17 21:00	1/3/17	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-85	103.92	33	-1	-6	13	D	-39	-28	-24	-29	-6	0	6	0	0	0	4	3
11/2/16 21:00	10/31/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-16	123.82	33	0	-1	14	D	-53	-28	-12	-29	-27	-15	-11	-4	-16	-16	-14	-8	0
8/2/16 21:00	8/1/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-22	176.57	33	0	-1	14	D	-27	-36	61	13	17	10	11	1	1	-5	-12	-27	-36
7/7/16 21:01	7/5/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-15	145.11	33	0	-1	14	D	-40	-41	-6	-13	2	0	0	0	6	1	14	6	-25
5/4/16 21:00	5/2/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-19	147.49	33	0	-1	14	D	-44	-45	-6	55	15	0	-7	-4	-1	1	19	21	-10
4/6/16 21:01	4/4/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-14	130.76	33	0	-1	14	D	-53	-45	-12	2	27	31	20	18	0	-11	-16	-13	-1	-34
2/3/16 21:00	2/1/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-13	103.56	33	0	-2	8	D	-68	-50	-63	-40	-39	-26	-18	-4	5	-4	28	52	77	10
1/5/16 21:01	1/4/16	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-68	145.90	33	0	-6	8	D	115	-7	-38	-14	-12	1	-4	-4	-8	-19	-36	0	-5	-33
11/4/15 21:00	11/2/15	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-20	160.24	33	0	-1	8	D	240	-29	-31	-30	0	7	8	10	-2	12	-16	-45	-26	-37
8/4/15 21:02	7/31/15	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-33	262.09	33	0	-3	4	D	464	13	38	-3	-2	1	-7	-4	0	-7	-30	-40	-64	-35
7/17/15 21:00	5/1/15	ICPT	Intercept Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	McMinn Rachel	NY	O	Chief St	S	-128	255.12	33	-1	-10	4	D	453	25	77	-1	12	4	13	11	0	1	-24	-39	-56	-47

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact